TERC Telomerase Subunit Gene Copy Number in Different Disease Stages of Non-Hodgkin Lymphoma and in Hepatitis C

REFERENCES

• Gajduskova, P.; Snijders, A.M.; Kwek, S.; Roydasgupta, R.; Fridlyand, J.; Tokuyasu, T.; Pinkel, D.; Albertson, D.G. Genome position and gene amplification. Genome Biol 2007, 8(6), R120.
   PubMedGoogle Scholar
• Harley, C.B.; Futcher, A.B.; Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345(6274), 458–460.
   PubMed Web of Science ®Google Scholar
• Allsopp, R.C.; Vaziri, H.; Patterson, C.; Goldstein, S.; Younglai, E.V.; Futcher, A.B.; Greider, C.W.; Harley, C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89(21), 10114–10118.
   PubMed Web of Science ®Google Scholar
• Counter, C.M.; Avilion, A.A.; LeFeuvre, C.E.; Stewart, N.G.; Greider, C.W.; Harley, C.B.; Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, (5), 1921–1929.
   PubMed Web of Science ®Google Scholar
• Edington, K.G.; Loughran, O.P.; Berry, I.J.; Parkinson, E.K. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog 1995, 13(4), 254–265.
   PubMed Web of Science ®Google Scholar
• Kim, N.W.; Piatyszek, M.A.; Prowse, K.R.; Harley, C.B.; West, M.D.; Ho, P.L.; Coviello, G.M.; Wright, W.E.; Weinrich, S.L.; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266(5193), 2011–2015.
   PubMed Web of Science ®Google Scholar
• Cao, Y.; Bryan, T.M.; Reddel, R.R. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 2008, 99(6), 1092–1099.
   PubMed Web of Science ®Google Scholar
• Bryce, L.A.; Morrison, N.; Hoare, S.F.; Muir, S.; Keith, W.N. Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization. Neoplasia 2000, 2(3), 197–201.
   PubMed Web of Science ®Google Scholar
• Soder, A.I.; Hoare, S.F.; Muire, S.; Balmain, A.; Parkinson, E.K.; Keith, W.N. Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting. Genomics 1997, 41(2), 293–294.
   PubMed Web of Science ®Google Scholar
• Monteverde, A.; Rivano, M.T.; Allegra, G.C.; Monteverde, A.I.; Zigrossi, P.; Baglioni, P.; Gobbi, M.; Falini, B.; Bordin, G.; Pileri, S. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988, 79(1), 20–25.
   PubMed Web of Science ®Google Scholar
• Coleman, W.B. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003, 3(6), 573–588.
   PubMed Web of Science ®Google Scholar
• Turner, N.C.; Dusheiko, G.; Jones, A. Hepatitis C and B-cell lymphoma. Ann Oncol 2003, 14(9), 1341–1345.
   PubMed Web of Science ®Google Scholar
• Satra, M.; Dalekos, G.N.; Kollia, P.; Vamvakopoulos, N.; Txezou, A. Telomerase reverse transcriptase mRNA expression in peripheral lymphocytes of patients with chronic HBV and HCV infections. J Viral Hepatitis 2005, 12, 488–493.
   PubMed Web of Science ®Google Scholar
• Armitage, J.O.; Weisenburger, D.D. New approach to classifying non-Hodgkin lymphoma: clinical features of the major histologic subtypes. J Clin Oncol 1998, 16, 2780–2795.
   PubMed Web of Science ®Google Scholar
• Gatter, K.C.; Warnke, R.A. Diffuse large B-cell lymphoma. In World Health Organization Classification of Tumors: Pathology and Genetics of Haematopoietic and Lymphoid Tissues, Jaffe E.S., Harris N.I., Stein H., and Vardiman J.W. (eds.) . Lyon, France, IARC Press, 2001, pp. 171–175.
   Google Scholar
• Hunt, K.E.; Reichard, K.K. Diffuse large B-cell lymphoma. Arch Pathol Lab Med 2008, 132, 118–124.
   PubMed Web of Science ®Google Scholar
• Widmann, T.A.; Herrmann, M.; Taha, N.; Konig, J.; Pfreudschuh, M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol 2007, 35, 939–946.
   PubMed Web of Science ®Google Scholar
• Campbell, L.J. Cytogenetics of lymphomas. Pathology 2005, 6, 493–507.
   Google Scholar
• Ventura, R.A. Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma. Leukemia 2004, 18, 1910–1911.
   PubMed Web of Science ®Google Scholar
• Amiel, A.; Elis, A.; Blumenthal, D.; Gaber, E.; Fejgin M.D.; Dubinsky, R., Lishner, M. Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 2001, 125, 156–160.
   PubMed Web of Science ®Google Scholar
• Goldberg-Bittman, L.; Kitay-Cohen, Y.; Hadary, R.; Yukla, M.; Fejgin, M.D.; Amiel, A. Random aneuploidy in chronic hepatitis C patients. Cancer Genet Cytogenet 2008, 108, 20–23.
   Google Scholar
• Sugita, M.; Tanaka, N.; Davidson, S.; Sekiya, S.; Varella-Garcia, M.; West, J.; Drabkin, H.A.; Gemmill, R.M. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 2000, 117(1), 9–18.
   PubMed Web of Science ®Google Scholar
• Knuutila, S.; Björkqvist, A.M.; Autio, K.; Tarkkanen, M.; Wolf, M.; Monni, O.; Szymanska, J.; Larramendy, M.L.; Tapper, J.; Pere, H.; El-Rifai, W.; Hemmer, S.; Wasenius, V.M.; Vidgren, V.; Zhu, Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998, 152(5), 1107–1123.
   PubMed Web of Science ®Google Scholar
• Neiman, P.E.; Elsaesser, K.; Loring, G.; Kimmel, R. Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis. PLoS Genet 2008, 4(7), e1000132.
   PubMedGoogle Scholar
• Karube, K.; Ying, G.; Tagawa, H.; Niino, D.; Aoki, R.; Kimura, Y.; Hashikawa, K.; Suefuji, N.; Sugita, Y.; Nomura, Y.; Shimizu, K.; Yoshida, S.; Seto, M.; Ohshima, K. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol 2008, 21(8), 973–978.
   PubMed Web of Science ®Google Scholar
• Young, K.H.; Xie, Q.; Zhou, G.; Eickhoff, J.C.; Sanger, W.G.; Aoun, P.; Chan, W.C. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event. Am J Clin Pathol 2008, 129(1), 157–166.
   PubMed Web of Science ®Google Scholar
• Ely, S.A.; Chadburn, A.; Dayton, C.M.; Cesarman, E.; Knowles, D.M. Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer 2000, 89(2), 445–452.
   PubMed Web of Science ®Google Scholar
• MacNamara, B.; Wang, W.; Chen, Z.; Hou, M.; Mazur, J.; Gruber, A.; Porwit-MacDonald, A. Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas. Haematologica 2001, 86(4), 386–393.
   PubMedGoogle Scholar
• Onur, I.; Akman, S.; Olgun, A.; Fen, T.; Kutluay, T. Peripheral blood telomerase activity in non-Hodgkin lymphoma. Res Commun Mol Pathol Pharmacol 2003, 113–114, 298–306.
   PubMedGoogle Scholar
• Klapper, W.; Krams, M.; Qian, W.; Janssen, D.; Parwaresch, R. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br J Cancer 2003, 89(4), 713–719.
   PubMed Web of Science ®Google Scholar
• Bodvarsdóttir, S.K.; Steinarsdóttir, M.; Hilmarsdóttir, H.; Jónasson, J.G.; Eyfjörd, J.E. MYC amplification and TERT expression in breast tumor progression. Cancer Genet Cytogenet 2007, 176(2), 93–99.
   PubMed Web of Science ®Google Scholar
• Wu, K.J.; Grandori, C.; Amacker, M.; Simon-Vermot, N.; Polack, A.; Lingner, J.; Dalla-Favera, R. Direct activation of TERT transcription by c-MYC. Nat Genet 1999, 21(2), 220–224.
   PubMed Web of Science ®Google Scholar
• Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., D.G. Haller, and Morrow M. (eds) . American Joint Committee on Cancer Staging Manual, 6th edition. Philadelphia, PA: Spinger, 2002.
   Google Scholar
• Xu, D.; Wang, Q.; Gruber, A.; Björkholm, M.; Chen, Z.; Zaid, A.; Selivanova, G.; Peterson, C.; Wiman, K.G.; Pisa, P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000, 19(45), 5123–5133.
   PubMed Web of Science ®Google Scholar
• Goldberg-Bittman, L.; Kitay-Cohen, Y.; Quitt, M.; Hadary, R.; Fejgin, M.D.; Yukla, M.; Amiel, A. Telomere aggregates in non-Hodgkin lymphoma patients at different disease stages. Cancer Genet Cytogenet 2008, 184(2), 105–108.
   PubMed Web of Science ®Google Scholar
• Blasco, M.A. Telomerase beyond telomeres. Nat Rev Cancer 2002, 2(8), 627–633.
   PubMed Web of Science ®Google Scholar
• Amiel, A.; Fejgin, M.D.; Goldberg-Bittman, L.; Sharoni, R, Hadary R.; Kitay-Cohen, Y. Telomeres aggregates in hepatitis C patients. Cancer Investig 2009, 27(6), 650–654.
   PubMed Web of Science ®Google Scholar
• Kitay-Cohen, Y.; Goldberg-Bittman, L.; Hadary, R.; Fejgin, M.D.; Amiel, A. Telomere length in Hepatitis C. Cancer Genet Cytogenet 2008, 187(1), 34–38.
   PubMed Web of Science ®Google Scholar